FDA Clears First-of-its-Kind Test to Distinguish Between Bacterial and Viral Infections
MeMed BV runs on the MeMed Key platform and provides results within 15 minutes.
Bacterial Infections
Diluent Mix-Up Prompts Recall of Firvanq Kits
Firvanq is indicated for the treatment of Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).
Phathom Seeks Approval of Vonoprazan-Based Regimens for H. Pylori Infection
The applications are based on data from the phase 3 PHALCON-HP trial.
Pneumococcal 15-Valent Conjugate Vaccine Immunogenic, Safe in Healthy Infants
The multicenter, randomized, double-blind, active-comparator-controlled phase 3 PNEU-PED study included 1720 healthy infants enrolled at 42-90 days of age.
Stop Using Ivermectin Veterinary Drug to Treat COVID-19, FDA Urges
No form of ivermectin has been approved to treat or prevent COVID-19, the agency emphasized
FDA: Stop Using Eco-Med Ultrasound Gels, Lotions
Health care providers, facilities should stop using and discard all ultrasound gels and lotions due to risk for bacterial contamination
MPR Weekly Dose Podcast Episode 90
This week we have significant news on the status of a third COVID-19 vaccine booster dose, as well as news for an encephalitis vaccine, another Jardiance indication, an FDA warning concerning patient wristbands, and Jemperli gets accelerated approval.
Omadacycline Gets Orphan Drug Status for Nontuberculous Mycobacteria Infections
The Company is evaluating oral omadacycline in approximately 75 adults with NTM pulmonary disease caused by MABc in an ongoing phase 2b study.
Lyme Disease Tied to Higher Risk for Psychiatric Conditions, Suicide
Risk particularly heightened in the six months following diagnosis
CDC: Fourth Case of Melioidosis Found in United States
Two of the four patients have died, the agency said Monday
